Építés alatt – nem éles oldal
Belépés
FelfüggesztveFázis nélkül

Feasibility Study of the AffloVest in Bronchiectasis

Megadott ok: Data analysis review of current data

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálat adatai

Ki végzi
Papworth Hospital NHS Foundation Trust
Azonosító
NCT04266873
A regiszteradat frissítve
2025. május 31.
Eredeti leírás
Feasibility study of High Frequency Chest Wall Oscillation (HFCWO) using the AffloVest in 30 patients with Bronchiectasis over a 6 week period. Outcome measures include lung function, quality of life questionnaire, High resolution computed Tomography and visual analogue scale for ease of clearance.A teljes eredeti leírásKevesebb

Measurement of Mucus Plugging With Computer Tomography Before and Following Implementation of the AffloVest in Adults With Bronchiectasis - a Feasibility Study'

Feasibility study of High Frequency Chest Wall Oscillation (HFCWO) using the AffloVest in 30 patients with Bronchiectasis over a 6 week period. Outcome measures include lung function, quality of life questionnaire, High resolution computed Tomography and visual analogue scale for ease of clearance.

Bevonási feltételek: Adult male and females 18 years or over; Current diagnosis of bronchiectasis; Productive of sputum on a daily basis; Clinical stability over a 2 week period prior to enrolment.

Kizáró feltételek: Severe obstructive airways disease (defined as FEV1 less than 25 percent); Predominant lung disease is not bronchiectasis in the opinion of the investigator (e.g. asthma, Chronic Obstructive Pulmonary Disease (COPD), pulmonary fibrosis); Currently treated non-tuberculous mycobacterial lung disease; Acute congestive cardiac failure; Contra-indication to using AffloVest including lung malignancy, recent rib fractures, radiological evidence of lung cavitation, and recent significant haemoptysis (in the opinion of the investigator); History of poor adherence to physiotherapy treatment; Cystic fibrosis; Bronchiectasis in only 1 lobe; Contra-indication or unable to perform HRCT imaging, including pregnancy; Cognitive or memory problems affecting ability to follow instructions or give informed consent.

ClinicalTrials.gov NCT04266873